Plasma 8-isoprostane concentrations in patients with age-related cataracts

Clinical Chemistry

Volumn 51, Issue 8, 2005, Pages 1541-1544

  Wang, Bin ^a   Zhu, Huaijun ^a   Sun, Hong ^a   Pan, Jinshun ^a   Yuan, Zhilan ^a   Yu, Rongbin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA;

AGED; AGING; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GERIATRIC PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE;

AGED; CASE-CONTROL STUDIES; CATARACT; DINOPROST; EXFOLIATION SYNDROME; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE;

EID: 23044450842     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.050955     Document Type: Article

References (29)

1. Congdon N, West SK, Buhrmann RR, Kouzis A, Munoz B, Mkocha H. Prevalence of the different types of age-related cataract in an African population. Invest Ophthatmol Vis Sci 2001;42:2478-82.
2. Jacques PF, Moeller SM, Hankinson SE, Chylack LT Jr, Rogers G, Tung W, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003;78:400-5.
3. Zigler JS Jr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S, et al. Tempol-H inhibits opacification of lenses in organ culture. Free Radic Biol Med 2003;35:1194-202.
4. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol 2005;38:103-19.
5. Garner B, Davies MJ, Truscott RJ. Formation of hydroxyl radicals in the human lens is related to the severity of nuclear cataract. Exp Eye Res 2000;70:81-8.
6. Marsili S, Salganik RI, Albright CD, Freel CD, Johnsen S, Peiffer RL, et al. Cataract formation in a strain of rats selected for high oxidative stress. Exp Eye Res 2004;79:595-612.
7. Yoshida M, Kimura H, Kyuki K, Ito M. Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet. Biol Pharm Bull 2004;27:338-44.
8. Gupta SK, Trivedi D, Srivastava S, Joshi S, Halder N, Verma SD. Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study. Nutrition 2003;19:794-9.
9. Chylack LT Jr, Brown NP, Bron A, Hurst M, Kopeke W, Thien U, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49-80.
10. Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC. Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002;132:1299-306.
11. 2-liKe compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990;87:9383-7.
12. Morrow JD, Roberts U. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
13. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004;18:1791-800.
14. Kim KM, Paeng KJ, Hahm JR, Kim DR, Chung BC. Elevated urinary 8-isoprostaglandin F(2α) in females with Graves' hyperthyroidism. Prostaglandins Leukot Essent Fatty Acids 2004;71:143-7.
15. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002;23:360-6.
16. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004;256:308-15.
17. 2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 2001;47:1974-9.
18. 2α and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003;87:353-6.
19. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76:397-403.
20. Schmidt-Erfurth U. Nutrition and retina. Dev Ophthalmol 2005;38:120-47.
21. Wang B, Zou Y, Li H, Van H, Pan JS, Yuan ZL. Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1α in a mouse model of oxygen-induced retinopathy. J Ocul Pharmacol Ther 2005;21:107-13.
22. Wang B, Li H, Yan H, Xiao JG. Genistein inhibited hypoxia inducible factor-1α expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells. Methods Find Exp Clin Pharmacol 2005;27:179-84.
23. Wang B, Zou Y, Yuan ZL, Xiao JG. Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. J Ocul Pharmacol Ther 2003;19: 457-64.
24. Kao CL, Chou CK, Tsai DC, Hsu WM, Liu JH, Wang CS, et al. Nitric oxide levels in the aqueous humor in cataract patients. J Cataract Refract Surg 2002;28:507-12.
25. Tarwadi K, Agte V. Linkages of antioxidant, micronutrient, and socioeconomic status with the degree of oxidative stress and lens opacity in Indian cataract patients. Nutrition 2004;20:261-7.
26. Ates NA, Yildirim O, Tamer L, Unlu A, Ercan B, Muslu N, et al. Plasma catalase activity and malondialdehyde level in patients with cataract. Eye 2004;18:785-8.
27. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr 1999;70:509-16.
28. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and β carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-52.
29. Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, et al. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract in Estonians. Invest Ophthalmol Vis Sci 2000;41:2262-7.